BridgeMD
New treatment option for Functional Constipation (FC)
Official title Effect of Lactobacillus DSM17938+ on Functional Constipation and Intestinal Flora in Pregnant Women
ClinicalTrials.gov ID: NCT06802042
What this study is testing
What is Lactulose oral solution treatment?
Lactulose oral solution treatment is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for functional constipation (fc).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Constipation (constipation) is a common clinical symptom, including difficulty in defecation and / or reduced frequency of defecation, dry and hard stool, difficulty in defecation, feeling of inexhaustible defecation, feeling of anorectal obstruction, time-consuming defecation and need for auxiliary defecation. Reduced defecation means defecation less than 3 times a week.Constipation is very common during pregnancy, and studies have found that the incidence of constipation in pregnant women is as high as 40%.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- (1) Pregnant women, age ≥18 years and \<40 years old, and gestational age \<28 weeks; (2) Must meet two or more of the following symptoms (Refer to...
- It is difficult to defecate at least 25% of the time;
- It is lumpy or hard stool at least 25% of the time;
- It is not enough to defecate at least 25% of the time;
- It is at least 25% of the time that there is anorectal obstruction or obstruction in defecation;
You likely can't join if
- (1) Non-pregnant women, age \<18 years or ≥40 years old, and gestational age ≥28 weeks; (2) Constipation caused by intestinal and systemic organic...
See the full eligibility criteria
- (1) Pregnant women, age ≥18 years and \<40 years old, and gestational age \<28 weeks; (2) Must meet two or more of the following symptoms (Refer to the Roman IV standard):
- It is difficult to defecate at least 25% of the time;
- It is lumpy or hard stool at least 25% of the time;
- It is not enough to defecate at least 25% of the time;
- It is at least 25% of the time that there is anorectal obstruction or obstruction in defecation;
- It requires manual assistance at least 25% of the time; ⑥It is spontaneous defecation less than 3 times a week. At the same time, loose stools rarely occur when no laxatives are used, which does not meet the diagnostic...
- (1) Non-pregnant women, age \<18 years or ≥40 years old, and gestational age ≥28 weeks; (2) Constipation caused by intestinal and systemic organic factors, drugs and other reasons, or concurrent with other...
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
- Wenzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China; Wenzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.